22.4 C
New York
Friday, August 23, 2019
Home Tags NMRD


Nemaura Publishes Positive Data from SugarBEAT® FDA Clinical Trial

LOUGHBOROUGH, England. Nemaura Medical Inc. (NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM)...

– $NMRD – Nemaura’s SugarBEAT Presented for CE Approval

Detroit, Dec 18th, 2018, (PENNYSTOCKS.NEWS). Nemaura Medical, Inc. (or the Company) (NASDAQ: $NMRD). The company is developing the sugarBEAT as an affordable,...

– $NMRD – Nemaura Continuing With the Public Offering

Detroit, Dec 18th,2018(PENNYSTOCKS.NEWS) Nemaura Medical Inc. (NASDAQ: $NMRD). Nemaura is a medical technology company in the United Kingdom, that is developing the...

Hot News